ocugen_4C_LOGO (002).png
Ocugen, Inc. Announces Connie Collingsworth Joins Business Advisory Board
September 21, 2023 07:30 ET | Ocugen
MALVERN, Pa., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
Coave Logo.png
Coave Therapeutics Appoints Genetic Medicine Expert Lolita Petit, PhD as Chief Scientific Officer
September 21, 2023 06:00 ET | Coave Therapeutics
Paris, France, September 21, 2023 – Coave Therapeutics (‘Coave’), a genetic medicine company focused on developing life-changing therapies for CNS (Central Nervous System) and eye diseases, announces...
Evaxion Logo.png
Evaxion Partners With Pharmaceutical Company Afrigen Biologics to Develop Novel mRNA Vaccine Against Gonorrhea
September 20, 2023 08:26 ET | Evaxion Biotech
Partnership based on a highly protective vaccine candidate identified by Evaxion’s EDEN™ platformThe collaboration will access mRNA technology from the WHO and Medicines Patent Pool’s mRNA Vaccine...
Genflow Biosciences PLC Announces Company Update
September 20, 2023 08:07 ET | GENFLOW BIOSCIENCES PLC
Successful first regulatory interaction with the Federal Agency for Medicines and Health Products (FAHMP) And Internal Debt Restructuring First regulatory agency interaction results in...
ocugen_4C_LOGO (002).png
Ocugen to Participate in Panel at Cantor Fitzgerald Global Healthcare Conference 2023
September 20, 2023 08:00 ET | Ocugen
MALVERN, Pa., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
Nouveau Logo communiqué de presse.JPG
Theratechnologies to Present at the Cantor Fitzgerald Global Healthcare Conference 2023
September 20, 2023 07:00 ET | Theratechnologies
MONTREAL, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...
Nouveau Logo communiqué de presse.JPG
Theratechnologies fera une présentation à la conférence Cantor Fitzgerald Global Healthcare 2023
September 20, 2023 07:00 ET | Theratechnologies
MONTRÉAL, 20 sept. 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique axée sur la mise au point...
Logo.PNG
HilleVax Announces Pricing of Public Offering of Common Stock
September 19, 2023 20:05 ET | HilleVax, Inc.
BOSTON, Sept. 19, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced the...
Logo.PNG
HilleVax Announces Proposed Public Offering of Common Stock
September 19, 2023 16:09 ET | HilleVax, Inc.
BOSTON, Sept. 19, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that it...
New logo with tagline.jpg
Vaxcyte to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference
September 19, 2023 16:05 ET | Vaxcyte, Inc.
SAN CARLOS, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the...